CATX logo

Perspective Therapeutics (CATX) Cash From Financing

Annual CFF

$785.00 K
+$757.00 K+2703.57%

December 1, 2023

Summary

Performance

1-Year Change

+2703.57%

3-Year Change

-98.79%

5-Year Change

-89.35%

15-Year Change

+8822.22%

CATX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.91%
CATX annual cash flow from financing activities is higher than 34.91% of companies in Healthcare sector

High & Low

All-time High

$91.75 M
CATX annual cash flow from financing activities is currently -99.14% below its historical high of $91.75 million

3-Year Low

$28.00 K
CATX annual cash flow from financing activities is currently +2703.57% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
CATX previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

Mar 28, 2025
CATX next annual earnings announcement is scheduled for Mar 28, 2025

OtherCATXcash flowmetrics:

Annual CFI

$24.37 M
CATX annual cash flow from investing activities is $24.37 million

Annual CFO

-$36.91 M
CATX annual cash flow from operations is -$36.91 million

Annual FCF

-$37.98 M
CATX annual free cash flow is -$37.98 million

Annual CAPEX

-
CATX annual capital expenditures value is unknown

Quarterly CFF

$628.00 K
-$121.46 M-99.49%

September 1, 2024

Summary

Performance

3-Month Change

-99.49%

1-Year Change

+62700%

3-Year Change

+885%

5-Year Change

+885%

CATX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

59.63%
CATX quarterly cash flow from financing activities is higher than 59.63% of companies in Healthcare sector

High & Low

All-time High

$166.33 M
CATX quarterly cash flow from financing activities is currently -99.62% below its historical high of $166.33 million

3-Year Low

-$80.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CATX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CATX next earnings announcement is scheduled for Mar 28, 2025

OtherCATXcash flowmetrics:

Quarterly CFI

-$29.74 M
CATX quarterly cash flow from investing activities is -$29.74 million

Quarterly CFO

$3.37 M
CATX quarterly cash flow from operations is $3.37 million

Quarterly FCF

-$26.35 M
CATX quarterly free cash flow is -$26.35 million

Quarterly CAPEX

-
CATX quarterly capital expenditures value is unknown

TTM CFF

$289.39 M
+$627.00 K+0.22%

September 1, 2024

Summary

Performance

3-Month Change

+0.22%

1-Year Change

+66734.18%

3-Year Change

+556623.08%

5-Year Change

+556623.08%

CATX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

92.38%
CATX TTM cash flow from financing activities is higher than 92.38% of companies in Healthcare sector

High & Low

All-time High

$289.39 M
CATX TTM cash flow from financing activities is currently at an all-time high

3-Year Low

-$52.00 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CATX previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CATX next earnings announcement is scheduled for Mar 28, 2025

OtherCATXcash flowmetrics:

TTM CFI

-$80.42 M
CATX TTM cash flow from investing activities is -$80.42 million

TTM CFO

-$696.00 K
CATX TTM cash flow from operations is -$696.00 thousand

TTM FCF

-$40.59 M
CATX TTM free cash flow is -$40.59 million

TTM CAPEX

-
CATX TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CATX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2703.6%+10000.0%+10000.0%
3 y3 years-98.8%+885.0%+10000.0%
5 y5 years-89.3%+885.0%+10000.0%

CATX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-98.8%+2703.6%-99.6%+885.0%at high>+9999.0%
5 y5-year-98.8%+2703.6%-99.6%+885.0%at high>+9999.0%
alltimeall time-99.1%+335.4%-99.6%+281.7%at high>+9999.0%

Perspective Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$628.00 K(-99.5%)
$289.39 M(+0.2%)
Jun 2024
-
$122.08 M(-26.6%)
$288.76 M(+72.7%)
Mar 2024
-
$166.33 M(>+9900.0%)
$167.19 M(>+9900.0%)
Dec 2023
$785.00 K(+2703.6%)
$352.00 K(>+9900.0%)
$785.00 K(+81.3%)
Sep 2023
-
$1000.00(-99.8%)
$433.00 K(-5.9%)
Jun 2023
-
$512.00 K(-740.0%)
$460.00 K(-984.6%)
Mar 2023
-
-$80.00 K(-385.7%)
-$52.00 K(-161.9%)
Dec 2022
$28.00 K(-50.0%)
-
-
Sep 2022
-
$28.00 K(>+9900.0%)
$84.00 K(+50.0%)
Jun 2022
-
$0.00(0.0%)
$56.00 K(-81.3%)
Jun 2022
$56.00 K(-99.9%)
-
-
Mar 2022
-
$0.00(-100.0%)
$299.00 K(-99.5%)
Dec 2021
-
$56.00 K(>+9900.0%)
$56.27 M(-13.0%)
Sep 2021
-
$0.00(-100.0%)
$64.68 M(0.0%)
Jun 2021
$64.68 M(+6407.4%)
-
-
Jun 2021
-
$243.00 K(-99.6%)
$64.68 M(-1.0%)
Mar 2021
-
$55.98 M(+561.3%)
$65.31 M(+589.7%)
Dec 2020
-
$8.46 M(+868.5%)
$9.47 M(+852.7%)
Jun 2020
$994.00 K(-86.5%)
$874.00 K(+567.2%)
$994.00 K(+647.4%)
Mar 2020
-
$131.00 K(-1290.9%)
$133.00 K(-2000.0%)
Dec 2019
-
-$11.00 K(-184.6%)
-$7000.00(-100.1%)
Jun 2019
$7.37 M(+1315.4%)
$13.00 K(-244.4%)
$7.37 M(-6.0%)
Mar 2019
-
-$9000.00(-92.7%)
$7.84 M(-0.1%)
Dec 2018
-
-$124.00 K(-101.7%)
$7.85 M(-2.0%)
Sep 2018
-
$7.49 M(+1454.8%)
$8.02 M(+1438.4%)
Jun 2018
$521.00 K(-5888.9%)
$482.00 K(>+9900.0%)
$521.00 K(+1235.9%)
Mar 2018
-
$0.00(-100.0%)
$39.00 K(0.0%)
Dec 2017
-
$39.00 K(>+9900.0%)
$39.00 K(-533.3%)
Sep 2017
-
$0.00(0.0%)
-$9000.00(0.0%)
Jun 2017
-$9000.00(-123.1%)
$0.00(0.0%)
-$9000.00(0.0%)
Mar 2017
-
$0.00(-100.0%)
-$9000.00(+50.0%)
Dec 2016
-
-$9000.00(<-9900.0%)
-$6000.00(-115.4%)
Jun 2016
$39.00 K(-86.3%)
$0.00(-100.0%)
$39.00 K(-67.1%)
Mar 2016
-
$3000.00(-127.3%)
$118.60 K(+2.2%)
Dec 2015
-
-$11.00 K(-123.4%)
$116.00 K(-0.3%)
Sep 2015
-
$47.00 K(-41.0%)
$116.40 K(-59.2%)
Jun 2015
$285.00 K(-98.8%)
$79.60 K(>+9900.0%)
$285.10 K(-51.8%)
Mar 2015
-
$400.00(-103.8%)
$591.30 K(-97.1%)
Dec 2014
-
-$10.60 K(-104.9%)
$20.39 M(+0.0%)
Sep 2014
-
$215.70 K(-44.1%)
$20.38 M(-13.1%)
Jun 2014
$23.45 M(+611.4%)
$385.80 K(-98.1%)
$23.45 M(+1.7%)
Mar 2014
-
$19.80 M(<-9900.0%)
$23.07 M(+605.3%)
Dec 2013
-
-$12.20 K(-100.4%)
$3.27 M(-0.2%)
Sep 2013
-
$3.28 M(>+9900.0%)
$3.28 M(-0.6%)
Jun 2013
$3.30 M(+6.2%)
$1800.00(>+9900.0%)
$3.30 M(-19.5%)
Mar 2013
-
$0.00(-100.0%)
$4.09 M(+0.1%)
Dec 2012
-
-$7000.00(-100.2%)
$4.09 M(-35.8%)
Sep 2012
-
$3.30 M(+313.6%)
$6.37 M(+105.1%)
Jun 2012
$3.10 M(+3.1%)
$798.30 K(<-9900.0%)
$3.10 M(+6.4%)
Mar 2012
-
-$5200.00(-100.2%)
$2.92 M(+0.3%)
Dec 2011
-
$2.27 M(+5547.8%)
$2.91 M(-5.0%)
Sep 2011
-
$40.20 K(-93.4%)
$3.06 M(+1.7%)
Jun 2011
$3.01 M
$610.60 K(-4796.9%)
$3.01 M(+30.3%)
Mar 2011
-
-$13.00 K(-100.5%)
$2.31 M(-0.2%)
DateAnnualQuarterlyTTM
Dec 2010
-
$2.42 M(<-9900.0%)
$2.31 M(-972.9%)
Sep 2010
-
-$11.90 K(-86.8%)
-$265.00 K(-2.0%)
Jun 2010
-$270.30 K(+164.5%)
-$90.00 K(+867.7%)
-$270.30 K(+31.7%)
Mar 2010
-
-$9300.00(-94.0%)
-$205.30 K(-8.2%)
Dec 2009
-
-$153.80 K(+794.2%)
-$223.60 K(+150.4%)
Sep 2009
-
-$17.20 K(-31.2%)
-$89.30 K(-12.6%)
Jun 2009
-$102.20 K(-115.6%)
-$25.00 K(-9.4%)
-$102.20 K(-39.8%)
Mar 2009
-
-$27.60 K(+41.5%)
-$169.80 K(-41.1%)
Dec 2008
-
-$19.50 K(-35.2%)
-$288.20 K(-1.7%)
Sep 2008
-
-$30.10 K(-67.5%)
-$293.10 K(-144.7%)
Jun 2008
$656.20 K(-97.5%)
-$92.60 K(-36.6%)
$656.30 K(+62.8%)
Mar 2008
-
-$146.00 K(+498.4%)
$403.20 K(-98.2%)
Dec 2007
-
-$24.40 K(-102.7%)
$21.87 M(-3.5%)
Sep 2007
-
$919.30 K(-365.9%)
$22.66 M(-15.3%)
Jun 2007
$26.77 M(+218.9%)
-$345.70 K(-101.6%)
$26.77 M(-6.5%)
Mar 2007
-
$21.32 M(+2683.2%)
$28.63 M(+158.4%)
Dec 2006
-
$766.10 K(-84.8%)
$11.08 M(-13.2%)
Sep 2006
-
$5.03 M(+232.3%)
$12.77 M(+52.1%)
Jun 2006
$8.39 M(-90.9%)
$1.51 M(-59.9%)
$8.39 M(+22.0%)
Mar 2006
-
$3.77 M(+53.6%)
$6.88 M(+121.2%)
Dec 2005
-
$2.46 M(+275.8%)
$3.11 M(+371.8%)
Sep 2005
-
$653.60 K(>+9900.0%)
$659.60 K(+5686.0%)
Jun 2005
$91.75 M(>+9900.0%)
-
-
Mar 2005
-
$2400.00(-33.3%)
$11.40 K(+7.5%)
Dec 2004
-
$3600.00(-5.3%)
$10.60 K(+7.1%)
Sep 2004
$9900.00(-47.9%)
$3800.00(+137.5%)
$9900.00(-24.4%)
Jun 2004
-
$1600.00(0.0%)
$13.10 K(-1.5%)
Mar 2004
-
$1600.00(-44.8%)
$13.30 K(-7.6%)
Dec 2003
-
$2900.00(-58.6%)
$14.40 K(-24.6%)
Sep 2003
$19.00 K(+113.5%)
$7000.00(+288.9%)
$19.10 K(+45.8%)
Jun 2003
-
$1800.00(-33.3%)
$13.10 K(+2.3%)
Mar 2003
-
$2700.00(-64.5%)
$12.80 K(-14.7%)
Dec 2002
-
$7600.00(+660.0%)
$15.00 K(+68.5%)
Sep 2002
$8900.00(-39.5%)
$1000.00(-33.3%)
$8900.00(+1.1%)
Jun 2002
-
$1500.00(-69.4%)
$8800.00(-51.4%)
Mar 2002
-
$4900.00(+226.7%)
$18.10 K(+28.4%)
Dec 2001
-
$1500.00(+66.7%)
$14.10 K(-4.1%)
Sep 2001
$14.70 K(+98.6%)
$900.00(-91.7%)
$14.70 K(-30.3%)
Jun 2001
-
$10.80 K(+1100.0%)
$21.10 K(+104.9%)
Mar 2001
-
$900.00(-57.1%)
$10.30 K(+9.6%)
Dec 2000
-
$2100.00(-71.2%)
$9400.00(+27.0%)
Sep 2000
$7400.00(-102.2%)
$7300.00(>+9900.0%)
$7400.00(-103.0%)
Jun 2000
-
$0.00(0.0%)
-$248.30 K(0.0%)
Mar 2000
-
$0.00(-100.0%)
-$248.30 K(+0.1%)
Dec 1999
-
$100.00(-100.0%)
-$248.10 K(-25.6%)
Sep 1999
-$333.50 K(+152.8%)
-$248.40 K(<-9900.0%)
-$333.50 K(+291.9%)
Jun 1999
-
$0.00(-100.0%)
-$85.10 K(0.0%)
Mar 1999
-
$200.00(-100.2%)
-$85.10 K(-0.2%)
Dec 1998
-
-$85.30 K
-$85.30 K
Sep 1998
-$131.90 K(-443.5%)
-
-
Sep 1997
$38.40 K(-96.5%)
-
-
Sep 1996
$1.09 M(+2514.7%)
-
-
Sep 1995
$41.60 K(-136.5%)
-
-
Sep 1994
-$113.90 K
-
-

FAQ

  • What is Perspective Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for Perspective Therapeutics?
  • What is Perspective Therapeutics annual CFF year-on-year change?
  • What is Perspective Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Perspective Therapeutics?
  • What is Perspective Therapeutics quarterly CFF year-on-year change?
  • What is Perspective Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Perspective Therapeutics?
  • What is Perspective Therapeutics TTM CFF year-on-year change?

What is Perspective Therapeutics annual cash flow from financing activities?

The current annual CFF of CATX is $785.00 K

What is the all time high annual CFF for Perspective Therapeutics?

Perspective Therapeutics all-time high annual cash flow from financing activities is $91.75 M

What is Perspective Therapeutics annual CFF year-on-year change?

Over the past year, CATX annual cash flow from financing activities has changed by +$757.00 K (+2703.57%)

What is Perspective Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of CATX is $628.00 K

What is the all time high quarterly CFF for Perspective Therapeutics?

Perspective Therapeutics all-time high quarterly cash flow from financing activities is $166.33 M

What is Perspective Therapeutics quarterly CFF year-on-year change?

Over the past year, CATX quarterly cash flow from financing activities has changed by +$627.00 K (+62700.00%)

What is Perspective Therapeutics TTM cash flow from financing activities?

The current TTM CFF of CATX is $289.39 M

What is the all time high TTM CFF for Perspective Therapeutics?

Perspective Therapeutics all-time high TTM cash flow from financing activities is $289.39 M

What is Perspective Therapeutics TTM CFF year-on-year change?

Over the past year, CATX TTM cash flow from financing activities has changed by +$288.96 M (+66734.18%)